{
  "docId": "019de075-d8f1-727b-b893-5e9d6af9a579",
  "docSlug": "880c8a38f766d3eb6660c74e922f5744",
  "documentTitle": "MindMed | Investor Presentation Deck | 32 slides",
  "authorId": "mindmed",
  "authorName": "MindMed",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 24,
  "pageCount": 32,
  "prevPage": 23,
  "nextPage": 25,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The chart shows improvement in social anxiety at 1 month and 6 months, indicating durability of effect.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-d8f1-727b-b893-5e9d6af9a579/24",
  "deckHref": "/decks/019de075-d8f1-727b-b893-5e9d6af9a579",
  "deckJsonHref": "/decks/019de075-d8f1-727b-b893-5e9d6af9a579.json",
  "deckAnchorHref": "/decks/019de075-d8f1-727b-b893-5e9d6af9a579#slide-24",
  "components": [
    {
      "bbox": {
        "h": 0.4,
        "w": 0.4,
        "x": 0.53,
        "y": 0.263
      },
      "kind": "chart",
      "text": "MDMA Reduces Social Anxiety in ASD",
      "attrs": null,
      "subkind": "bar-grouped",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8d132e3f-1dbc-415b-bf4b-9b13acf6b9a0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.4,
        "x": 0.07,
        "y": 0.263
      },
      "kind": "list",
      "text": "MM-402 or R(-)-MDMA is a pharmaceutically optimized enantiomer of MDMA. Potential first-in-class therapy for core symptoms of ASD. Pilot clinical data suggest racemic MDMA could enhance social functioning. Pharmacological profile aligns with patient-desired treatment benefits",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2476d087-2f30-4b9f-a0ba-30588f817e3b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.7,
        "x": 0.05,
        "y": 0.09
      },
      "kind": "paragraph",
      "text": "Pilot clinical trial results of MDMA demonstrate acute and durable positive effects on social functioning in ASD population",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4dee9fdb-eb19-4631-b14c-f85eebe5f600",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.05,
        "x": 0.53,
        "y": 0.75
      },
      "kind": "source-note",
      "text": "Source: [1]",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e497aa9f-6ba6-4391-bc7c-92a6eac8d60e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.05,
        "y": 0.03
      },
      "kind": "title",
      "text": "Clinical Data Support Opportunity for MDMA in ASD",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b828057f-355e-4863-b579-9e8ad8512816",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}